Advertisement

Topics

Eurand Company Profile

09:08 EDT 23rd September 2017 | BioPortfolio

Eurand is a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products using our innovative drug delivery technologies. The Company’s drug development efforts are based on three commercialized technology platforms; bioavailability enhancement of poorly soluble drugs, customized release and taste masked/fast dissolving formulations. Eurand has recently added a fourth technology platform, drug targeting, to its capabilities that, once commercialized, can be applied to small molecule and biotechnology derived products for improved drug delivery.

Location

845 Center Drive
Vandalia
Ohio
45377
United States of America

Contact

Phone: 937-898-9669
Fax: 937-898-9529
Email: bizdev@eurand.com


News Articles [0 Results]

None

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Zenpep [Eurand Pharmaceuticals Inc.]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP (pancrelipase) delayed release capsules Initial U.S...

Pancrelipase [KAISER FOUNDATION HOSPITALS]

Pancrelipase [X-GEN Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use pancrelipase safely and effectively. See full prescribing information for pancrelipase. pancrelipase (pancrelipase) CAPSULE, DELAYED R...

Potassium chloride [Eurand, Inc.]

These highlights do not include all the information needed to use Potassium Chloride Extended Release Tablets, USP 20 mEq safely and effectively. See full prescribing information for Potassium Chlorid...

PubMed Articles [0 Results]

None

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Safety and Efficacy of Eurand Pancreatic Enzyme Product (PEP) in Patients With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

The primary efficacy objective of this study is to compare the coefficient of fat absorption (CFA) following oral administration of Eurand PEP capsules or placebo in patients with cystic f...

An Open Label,Safety Extension of Eurand Study PR-011

A Study to determine long term safety of EUR-1008 3,000 lipase units capsules (the "EUR-1008"), a Pancreatic Enzyme Product ("PEP"), in infants with CF who need to take PEP medications to ...

Study of Pancreatic Enzyme Product in Pediatric Patients With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

This is an open-label study to evaluate the safety and efficacy of Eurand pancreatic enzyme product (PEP) microtabs in pediatric patients under age 7 with Cystic Fibrosis and Exocrine Panc...

Companies [1 Associated Companies listed on BioPortfolio]

Eurand

Eurand is a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products using our innovative drug delivery technologies. The Company’s drug development effo...

More Information about "Eurand" on BioPortfolio

We have published hundreds of Eurand news stories on BioPortfolio along with dozens of Eurand Clinical Trials and PubMed Articles about Eurand for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eurand Companies in our database. You can also find out about relevant Eurand Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record